Increase in hippocampal Tau phosphorylation was observed in 3xTg-AD mice, compared to WT animals, at [Ser396]; the phosphorylation then tended to attenuate after treatment with all tested compounds (Fig. 7.C). Here, MAPT is linked to Alzheimer disease.